Literature DB >> 4352019

Adriamycin--an antitumor antibiotic in the treatment of neoplastic diseases.

C Tan, E Etcubanas, N Wollner, G Rosen, A Gilladoga, J Showel, M L Murphy, I H Krakoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4352019     DOI： 10.1002/1097-0142(197307)32:1<9::aid-cncr2820320102>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  22 in total

Review 1.  Doxorubicin effects on contractile structures and molecules.

Authors:  R Colombo; A Milzani; A Necco; G Vailati
Journal:  Cytotechnology       Date:  1990-01       Impact factor: 2.058

2.  Chemical and morphologic alterations of rabbit bone induced by adriamycin.

Authors:  D M Young; J L Fioravanti; H M Olson; D J Prieur
Journal:  Calcif Tissue Res       Date:  1975-07-04

3.  Adriamycin-Induced Models of VACTERL Association.

Authors:  D Mc Laughlin; P Hajduk; P Murphy; P Puri
Journal:  Mol Syndromol       Date:  2013-02

Review 4.  Anthracycline analogs: the past, present, and future.

Authors:  R B Weiss; G Sarosy; K Clagett-Carr; M Russo; B Leyland-Jones
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium.

Authors:  Shasi V Kalivendi; Eugene A Konorev; Sonya Cunningham; Sravan K Vanamala; Eugene H Kaji; Joy Joseph; B Kalyanaraman
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

Review 6.  New advances in surgical oncology.

Authors:  D L Morton; F R Eilber; F K Storm; D H Kern
Journal:  West J Med       Date:  1983-09

7.  Cutaneous Toxicity in a Laboratory Beagle (Canis lupus familiaris) after Chronic Administration of Doxorubicin Hydrochloride.

Authors:  Kathryn A Guerriero; Steven R Wilson; Nabil E Boutagy; Chi Liu; Albert J Sinusas; Caroline J Zeiss
Journal:  Comp Med       Date:  2018-02-01       Impact factor: 0.982

8.  Doxorubicin-mediated apoptosis in glioma cells requires NFAT3.

Authors:  Sreelatha Gopinath; Sravan K Vanamala; Meena Gujrati; Jeffrey D Klopfenstein; Dzung H Dinh; Jasti S Rao
Journal:  Cell Mol Life Sci       Date:  2009-09-27       Impact factor: 9.261

9.  A standardized extract of Ginkgo biloba suppresses doxorubicin-induced oxidative stress and p53-mediated mitochondrial apoptosis in rat testes.

Authors:  Y-C Yeh; T-J Liu; L-C Wang; H-W Lee; C-T Ting; W-L Lee; C-J Hung; K-Y Wang; H-C Lai; H-C Lai
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

Review 10.  Update on systemic therapy for advanced soft-tissue sarcoma.

Authors:  A Smrke; Y Wang; C Simmons
Journal:  Curr Oncol       Date:  2020-02-01       Impact factor: 3.677
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.